Long Qian
Impact in
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- RNA modifications and cancer 15
- Circular RNAs in diseases 8
- Gut microbiota and health 7
- Epigenetics and DNA Methylation 7
- Ubiquitin and proteasome pathways 6
-
- Cancer-related molecular mechanisms research 14
- MicroRNA in disease regulation 12
- Co-authors
- Zhijie Xu (26 shared papers)Yuanliang Yan (26 shared papers)Zhicheng Gong (25 shared papers)Shuangshuang Zeng (23 shared papers)Lun‐Quan Sun (4 shared papers)Shuang Dai (5 shared papers)Jie Wei (15 shared papers)Hao Zhang (5 shared papers)
- Journals
- Frontiers in Oncology (8 papers)Frontiers in Immunology (6 papers)Theranostics (4 papers)Annals of Translational Medicine (3 papers)Cell Death and Disease (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Long Qian
146 papers receiving 3.2k citations
Long Qian's Hit Papers
Peers
Comparison fields: 5 of 137
- Biological Psychiatry 183
- Cancer Research 667
- Molecular Biology 1.6k
- Gastroenterology 89
- Immunology 295
Countries citing papers authored by Long Qian
This map shows the geographic impact of Long Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long Qian more than expected).
Fields of papers citing papers by Long Qian
This network shows the impact of papers produced by Long Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long Qian. The network helps show where Long Qian may publish in the future.
Co-authors
The 25 scholars most cited alongside Long Qian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 154 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bifidobacterium breve CCFM1025 attenuates major depression disorder via regulating gut microbiome and tryptophan metabolism: A randomized clinical trial Hit paper breakdown → | 2021 | 267 |
| 2 | 2016 | 250 | |
| 3 | 2020 | 109 | |
| 4 | 2022 | 95 | |
| 5 | 2019 | 91 | |
| 6 | 2019 | 86 | |
| 7 | 2019 | 82 | |
| 8 | T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome. | 2007 | 78 |
| 9 | 2018 | 74 | |
| 10 | 2019 | 68 | |
| 11 | 2021 | 56 | |
| 12 | 2019 | 55 | |
| 13 | 2022 | 54 | |
| 14 | 2017 | 52 | |
| 15 | 2019 | 47 | |
| 16 | 2018 | 47 | |
| 17 | 2019 | 47 | |
| 18 | 2018 | 46 | |
| 19 | 2017 | 46 | |
| 20 | 2020 | 45 |
About Long Qian
Long Qian is a scholar working on Molecular Biology, Cancer Research, Immunology, Oncology and Rheumatology, having authored 154 papers that have together received 3.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (15 papers), Cancer-related molecular mechanisms research (14 papers), MicroRNA in disease regulation (12 papers), Circular RNAs in diseases (8 papers), Gut microbiota and health (7 papers), Epigenetics and DNA Methylation (7 papers), Ferroptosis and cancer prognosis (7 papers) and Ubiquitin and proteasome pathways (6 papers). The work is most often cited by research in Biological Psychiatry (183 citations), Cancer Research (667 citations), Molecular Biology (1.6k citations), Gastroenterology (89 citations) and Immunology (295 citations). Long Qian has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhijie Xu, Yuanliang Yan, Zhicheng Gong, Shuangshuang Zeng, Lun‐Quan Sun, Shuang Dai, Jie Wei, Hao Zhang, Wei Chen and Luyao Wang. Their work appears in journals such as Frontiers in Oncology, Frontiers in Immunology, Theranostics, Annals of Translational Medicine and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.